Health4 hours ago
AstraZeneca Achieves Milestone in SLE Treatment with Saphnelo
AstraZeneca announced on October 25, 2023, that its Phase 3 trial for an injectable version of Saphnelo (anifrolumab) successfully met its primary endpoint. This therapy targets...